| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | GSK-1904529A | GDSC1000 | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | BRD-K49290616 | CTRPv2 | pan-cancer | AAC | 0.0032 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |